GammaDelta Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 1-10 Employees

GammaDelta Therapeutics revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$1,667,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	No funding

Key Contacts at GammaDelta Therapeutics

Paolo Paoletti

Ceo

Emma Roffe

Director

Company overview

Headquarters	London, England, United Kingdom
Phone number	+442076911122
Websites	gammadeltatx.com takeda.com
Keywords	Immunotherapy, Immunology, Gamma Delta T Cells, Car T Cells, Innate Immune Cells
Founded	2016
Employees	1-10
Socials

About GammaDelta Therapeutics

GammaDelta Therapeutics is a UK headquartered biotechnology company founded upon world-class academic research conducted by Professor Adrian Hayday and Dr Oliver Nussbaumer, at King’s College London and the Francis Crick Institute and supported by Cancer Research Technology. GammaDelta Therapeutics aims to harness the unique properties of γδ T cells to improve patient outcomes and survival rates among patients with haematological malignancies and solid tumours. Our mission is to deliver highly effective allogeneic immunotherapies based on the unique properties of Vδ1+ T cells with potential to provide additional benefits towards patient survival in the treatment of cancers. Our proprietary isolation and expansion protocols have the ability to selectively generate Vδ1+ T cell populations suitable for clinical application. The Company’s technologies are based upon pioneering world-class research conducted by Professor Adrian Hayday and Dr Oliver Nussbaumer, at King’s College London and the Francis Crick Institute, and Professor Bruno Silva-Santos at the University of Lisbon. GammaDelta’s technology has been recognised for its therapeutic potential, attracting interest from the pharmaceutical industry and investment from Takeda Pharmaceutical Company Limited and Abingworth LLP.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Employees by Department

GammaDelta Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

GammaDelta Therapeutics has never raised funding before.

GammaDelta Therapeutics Tech Stack

Discover the technologies and tools that power GammaDelta Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Amazon Web Services

PaaS

Next.js

JavaScript frameworks

Cloudflare Bot Management

Security

Google Tag Manager

Tag managers

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Cloudflare Browser Insights

Analytics

Webpack

Miscellaneous

Brightcove

Video players

OneTrust

Cookie compliance

Frequently asked questions

GammaDelta Therapeutics is located in London, England, GB.

You can reach GammaDelta Therapeutics at +442076911122.

GammaDelta Therapeutics generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

GammaDelta Therapeutics has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

GammaDelta Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

GammaDelta Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at GammaDelta Therapeutics

Paolo Paoletti

Ceo

Emma Roffe

Director

4.8

40,000 users